Frequency of CD4+CD25hiFOXP3+ Regulatory T Cells Has Diagnostic and Prognostic Value as a Biomarker for Acute Graft-Versus-Host Disease.
John Magenau(University of Michigan), Sophie Paczesny(MUSC Hollings Cancer Center), Daniel Bickley(University of Michigan), James L.M. Ferrara(Tisch Hospital), Matthew Schlough(University of Michigan), Isao Tawara(Mie University), John E. Levine(Icahn School of Medicine at Mount Sinai), Xuemei Qin(Shanxi University), Sung Won Choi(University of Michigan), Shin Mineishi(University of Alabama at Birmingham), Thomas Braun(University of Michigan), Pil Sang Jang(University of Michigan), Clare Rogers(Doncaster and Bassetlaw Teaching Hospitals NHS Foundation Trust), Dawn Jones(University of Michigan), Kathleen P. Lowler(University of Michigan)
Cited by 18
Related Papers
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases
|Frontiers in Immunology|2017|612
Myeloablative Autologous Stem-Cell Transplantation for Severe Scleroderma
|New England Journal of Medicine|2018|598
Genetic mechanisms of target antigen loss in CAR19 therapy of acute lymphoblastic leukemia
|Nature Medicine|2018|577
Blood and Marrow Transplant Clinical Trials Network Toxicity Committee Consensus Summary: Thrombotic Microangiopathy after Hematopoietic Stem Cell Transplantation
|Biology of Blood and Marrow Transplantation|2005|458